安慰剂
混淆
安慰剂反应
背景(考古学)
干预(咨询)
心理干预
临床研究设计
临床试验
研究设计
天花板效应
样本量测定
心理学
医学
物理疗法
物理医学与康复
临床心理学
精神科
替代医学
统计
内科学
数学
生物
病理
古生物学
作者
Filipe B. Rodrigues,Joaquim J. Ferreira
出处
期刊:International Review of Neurobiology
日期:2020-01-01
卷期号:: 49-70
被引量:5
标识
DOI:10.1016/bs.irn.2020.04.002
摘要
Placebo-controlled trials are the research standard to evaluate new interventions for which there is no standard of care. While lessening performance and detection bias, such design provides a direct mode of comparison against the probed intervention. Still, using placebo arms may pose new challenges to the design, conduct and analysis of clinical trials. This is particularly relevant in circumstances of non-additivity between the therapeutic and the placebo effects, if the outcome of interest has floor or ceiling effects, or when the predicted effect size of the intervention is large and leads to small sample sizes. There are several possible strategies to mitigate the confounding effects of the placebo, each relevant to specific clinical trial designs. This chapter puts into context the new challenges created by the placebo effect, discusses possible ways around them, and explores the future of the field.
科研通智能强力驱动
Strongly Powered by AbleSci AI